Literature DB >> 7686911

Novel delayed-early and highly insulin-induced growth response genes. Identification of HRS, a potential regulator of alternative pre-mRNA splicing.

R H Diamond1, K Du, V M Lee, K L Mohn, B A Haber, D S Tewari, R Taub.   

Abstract

We have identified 41 novel and many previously known growth response genes induced in regenerating liver and insulin-treated Reuber H35 cells, a rat hepatoma cell line that grows in response to physiologic concentrations of insulin and retains some properties of regenerating liver. Although many genes are expressed similarly in the two systems, there are important differences in the kinetics of induction of some genes. These differences allowed us to identify and characterize novel genes that are highly insulin-induced and expressed as delayed-early genes in regenerating liver. Sequence analysis of CL-6, the most abundant insulin-induced gene, resulted in the identification of a highly hydrophobic hepatic protein. Sequence analysis of HRS, a highly insulin-induced delayed-early gene, demonstrated that it is a member of the family of regulators of alternative pre-mRNA splicing. Different forms of HRS mRNA are temporally regulated during the growth response, suggesting that HRS could autoregulate processing of its pre-mRNA. Given the dramatic increase in RNA production during late G1, proteins induced by mitogens like insulin that control RNA processing are likely to have important roles in cell cycle regulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686911

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

2.  Functional properties of p54, a novel SR protein active in constitutive and alternative splicing.

Authors:  W J Zhang; J Y Wu
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

3.  Characterization of SRp46, a novel human SR splicing factor encoded by a PR264/SC35 retropseudogene.

Authors:  J Soret; R Gattoni; C Guyon; A Sureau; M Popielarz; E Le Rouzic; S Dumon; F Apiou; B Dutrillaux; H Voss; W Ansorge; J Stévenin; B Perbal
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

4.  Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats.

Authors:  L P Lim; P A Sharp
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

5.  HRS/SRp40-mediated inclusion of the fibronectin EIIIB exon, a possible cause of increased EIIIB expression in proliferating liver.

Authors:  K Du; Y Peng; L E Greenbaum; B A Haber; R Taub
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

6.  Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer.

Authors:  R Tacke; Y Chen; J L Manley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

7.  Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors.

Authors:  E Birney; S Kumar; A R Krainer
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

8.  CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy.

Authors:  L E Greenbaum; W Li; D E Cressman; Y Peng; G Ciliberto; V Poli; R Taub
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  The hypocholesterolemic agent LY295427 up-regulates INSIG-1, identifying the INSIG-1 protein as a mediator of cholesterol homeostasis through SREBP.

Authors:  Bethany A Janowski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

10.  INSIG1 influences obesity-related hypertriglyceridemia in humans.

Authors:  E M Smith; Y Zhang; T M Baye; S Gawrieh; R Cole; J Blangero; M A Carless; J E Curran; T D Dyer; L J Abraham; E K Moses; A H Kissebah; L J Martin; M Olivier
Journal:  J Lipid Res       Date:  2009-10-21       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.